Lymphoma clinical trials
1 Lymphoma trials (Malignant Hematology) summarized for clinical practice and board review, newest first within each disease. Each summary covers design, results, toxicity and what changed in practice.
PTCL (1)
- AC-CHOP in PTCL Blood Cancer J 2026Adding azacitidine + chidamide to CHOP did not significantly improve ORR or PFS. OS gain should be interpreted cautiously.